Clinical breast cancer, new developments in selection and endocrine treatment of patients
- 1 September 1992
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 43 (1-3), 211-221
- https://doi.org/10.1016/0960-0760(92)90210-a
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptorsEuropean Journal Of Cancer, 1992
- c-erbB-2 oncogene as a prognostic marker in breast cancerBritish Journal of Cancer, 1991
- Cancer in the European community and its member statesEuropean Journal of Cancer and Clinical Oncology, 1990
- Prognostic assessment in node-negative breast cancer patients.Journal of Clinical Oncology, 1990
- New developments in the molecular biology of breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Node negative breast cancer.BMJ, 1990
- 2. Molecular lesions in breast cancerInternational Journal of Cancer, 1990
- Adjuvant Therapy of Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Oncogenes in clinical cancer — A panel discussionBreast Cancer Research and Treatment, 1987